Sign in

CIK 0001750149 · Non-accelerated filer<br>Smaller reporting company

Inhibikase Therapeutics, Inc.

Sign in to watch
Ticker
IKT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
263407249
Phone
(302) 295-3800
Business address
1000 N. WEST STREET, SUITE 1200, WILMINGTON, DE, 19801
  1. SC 13G Stake Amended Statement of Ownership
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 14F1 Other SC 14F1
  4. 8-K Event Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure · Other events
  5. SC 13G Stake Amended Statement of Ownership
  6. 8-K Event Regulation FD disclosure
  7. 10-Q Report Quarterly Report
  8. 8-K Event Shareholder vote results
  9. 4 Insider Changes in Ownership
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 424B3 Offering Prospectus
  14. EFFECT Other Notice of Effectiveness
  15. CORRESP Other Correspondence Between Filers and SEC Staff
  16. DEFA14A Proxy Proxy Materials
  17. UPLOAD Other SEC-generated Letter
  18. DEF 14A Proxy Proxy Statement
  19. S-1 Offering Registration Statement
  20. PRE 14A Proxy Proxy Statement (Preliminary)

Page 9 of 19 · 370 filings